BioRestorative Therapies (BRTX) Projected to Post Quarterly Earnings on Friday

BioRestorative Therapies (NASDAQ:BRTX) is anticipated to issue its quarterly earnings data before the market opens on Friday, April 4th. Analysts expect BioRestorative Therapies to post earnings of ($0.27) per share and revenue of $0.48 million for the quarter.

BioRestorative Therapies (NASDAQ:BRTX) last released its quarterly earnings data on Thursday, March 27th. The company reported ($0.20) earnings per share for the quarter, topping the consensus estimate of ($0.27) by $0.07. The firm had revenue of $0.50 million for the quarter, compared to the consensus estimate of $0.48 million. BioRestorative Therapies had a negative net margin of 2,697.08% and a negative return on equity of 98.49%. On average, analysts expect BioRestorative Therapies to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

BioRestorative Therapies Price Performance

Shares of NASDAQ BRTX opened at $1.85 on Thursday. The company has a 50-day moving average price of $1.95 and a 200-day moving average price of $1.73. The stock has a market capitalization of $12.80 million, a P/E ratio of -1.21 and a beta of 64.37. BioRestorative Therapies has a 1 year low of $1.03 and a 1 year high of $2.55.

About BioRestorative Therapies

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.